A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Article

Nghiemphu, Phioanh Leia, Wen, Patrick Y, Lamborn, Kathleen R et al. (2011). A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1422-1427. 10.1016/j.ijrobp.2010.07.1997

Open Access

cited authors

  • Nghiemphu, Phioanh Leia; Wen, Patrick Y; Lamborn, Kathleen R; Drappatz, Jan; Robins, H Ian; Fink, Karen; Malkin, Mark G; Lieberman, Frank S; DeAngelis, Lisa M; Torres-Trejo, Alejandro; Chang, Susan M; Abrey, Lauren; Fine, Howard A; Demopoulos, Alexis; Lassman, Andrew B; Kesari, Santosh; Mehta, Minesh P; Prados, Michael D; Cloughesy, Timothy F

sustainable development goals

authors

publication date

  • December 1, 2011

webpage

published in

keywords

  • ANTIEPILEPTIC DRUGS
  • CONCOMITANT
  • FARNESYLTRANSFERASE INHIBITOR
  • Farnesyltransferase inhibitor
  • GROWTH
  • GUANOSINE TRIPHOSPHATE
  • Life Sciences & Biomedicine
  • Newly diagnosed glioblastoma
  • Oncology
  • PROTEIN TRANSFERASE INHIBITOR
  • R115777
  • RADIOTHERAPY
  • RAS
  • RECURRENT MALIGNANT GLIOMA
  • Radiation
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • Temozolomide
  • Tipifarnib

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1422

end page

  • 1427

volume

  • 81

issue

  • 5